RepliCel Life Sciences Owners

Materials & Resources » Mining, Metals & Minerals | RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

BBVA Asset Management SA SGIIC

309,883

1.8%

-31,266

12/31/2017

Arrow Capital Management, Inc.

-64,000

06/30/2018

View Profile

Address	570 Granville Street Vancouver British Columbia V6C 3P1 Canada
Employees	-
Website	http://www.replicel.com
Updated	07/08/2019
RepliCel Life Sciences, Inc. is a regenerative medicine company, which focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.